EyePoint Pharmaceuticals
EYPT
EYPT
39 hedge funds and large institutions have $29.9M invested in EyePoint Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
39
Holding in Top 10
–
Calls
$634K
Puts
$77K
Top Buyers
| 1 | +$271K | |
| 2 | +$148K | |
| 3 | +$82.4K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$35.5K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
+$32K |
Top Sellers
| 1 | -$818K | |
| 2 | -$339K | |
| 3 | -$189K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$79.7K |
| 5 |
Goldman Sachs
New York
|
-$57K |